Novo CEO pressed by Senate to cut price ranges of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the corporation would take into account new talks with insurers about the checklist selling prices of Wegovy and copyright if they pledge to help keep the medicines on their own https://gregorypgwmc.activablog.com/30079270/5-simple-techniques-for-healthcare-news